Prosecution Insights
Prosecution Insights
7 pending office actions • 7 clients • 7 examiners • 5 art units • 0 of 7 (0%) have an AI response strategy ready
Based on the USPTO statutory response window for each pending office action. 4 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.
Every pending office action with a known statutory deadline, placed on a days-until-due axis. Dots left of Today are overdue; the further right, the more runway. Cases that share a deadline window stack vertically. 4 of the docket's apps have a known mailing date.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §103 only | 4 (57%) |
| Double-patenting only | 1 (14%) |
| Double-patenting + other | 1 (14%) |
| Multi-statute (no §101) | 1 (14%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| TCHERKASSKAYA, OLGA V | 1 | 55.3% | +46.2% |
| PHAN, DOAN THI-THUC | 1 | 42.4% | +48.7% |
| ARNOLD, ERNST V | 1 | 48.1% | +13.0% |
| KUO, JONATHAN T | 1 | 72.4% | +27.6% |
| SCHMIDT, IZABELA MARIA | 1 | 64.2% | +44.5% |
| PETRITSCH, AMANDA MICHELLE | 1 | 57.3% | +31.5% |
| NOLAN, JASON MICHAEL | 1 | 66.3% | -28.0% |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18626760 | COSMETIC EMULSION BASES (CEB) | PHAN, DOAN THI-THUC | 16d overdue |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 6 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18626760 | COSMETIC EMULSION BASES (CEB) | PHAN, DOAN THI-THUC | 16d overdue |
| 18192624 | Anti-Oncogenic Phytochemicals and Methods and Uses for Treating Cancer | SCHMIDT, IZABELA MARIA | 21d |
| 18595716 | Solid Solution Compositions and Use in Severe Pain | ARNOLD, ERNST V | 61d |
| 18847245 | Compositions Having Improved Bioavailability of Therapeutics and Uses Thereof | TCHERKASSKAYA, OLGA V | — |
| 18392699 | Photobiomodulation Therapy Garment, Methods and Uses | KUO, JONATHAN T | — |
| 17596570 | Compositions, Kits, Methods and Uses for Preventing Microbial Growth | PETRITSCH, AMANDA MICHELLE | — |
| Client (Assignee) | Pending OAs |
|---|---|
| Trx Biosciences Limited | 1 |
| Suncoast Products LLC | 1 |
| Infirst Healthcare Limited | 1 |
| Niraxx, Inc. | 1 |
| Ostentus Therapeutics, Inc. | 1 |
| Collidion | 1 |
| Irvine Labs, Inc. | 1 |
| Art Unit | Apps |
|---|---|
| 1613 | 2 |
| 3792 | 1 |
| 1621 | 1 |
| 1612 | 1 |
| 1623 | 1 |
| App # | Title | Client | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|---|
| 18847245 | Compositions Having Improved Bioavailability of Therapeutics and Uses Thereof | Trx Biosciences Limited | TCHERKASSKAYA, OLGA V | DP | Non-Final OA | — | Pending | Sep 14, 2024 | |
| 18626760 | COSMETIC EMULSION BASES (CEB) | Suncoast Products, LLC | PHAN, DOAN THI-THUC | 1613 | §103§112Other | Non-Final OA | 16d overdue | Pending | Apr 04, 2024 |
| 18595716 | Solid Solution Compositions and Use in Severe Pain | Infirst Healthcare Limited | ARNOLD, ERNST V | 1613 | §103DPOther | Non-Final OA | 61d | Pending | Mar 05, 2024 |
| 18392699 | Photobiomodulation Therapy Garment, Methods and Uses | Niraxx, Inc. | KUO, JONATHAN T | 3792 | §103 | Final Rejection | — | Pending | Dec 21, 2023 |
| 18192624 | Anti-Oncogenic Phytochemicals and Methods and Uses for Treating Cancer | Ostentus Therapeutics, Inc. | SCHMIDT, IZABELA MARIA | 1621 | §103Other | Non-Final OA | 21d | Pending | Mar 29, 2023 |
| 17596570 | Compositions, Kits, Methods and Uses for Preventing Microbial Growth | Collidion, Inc. | PETRITSCH, AMANDA MICHELLE | 1612 | §103 | Final Rejection | — | Pending | Dec 13, 2021 |
| 17191470 | Cannabis Treatment of Insomnia, Pain, and Skin Conditions | Irvine Labs, Inc. | NOLAN, JASON MICHAEL | 1623 | §103 | Final Rejection | 7d | Pending | Mar 03, 2021 |
IP Author helps law firms respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free Trial